CALGARY, Alberta, July 21, 2017 -- Husky Energy’s regular dividend payments on each of the Cumulative Redeemable Preferred Shares – Series 1, Series 2, Series 3, Series 5 and Series 7 – will be paid for the three-month period ended September 30, 2017. The dividends will be payable on October 2, 2017 to holders of record at the close of business on August 28, 2017.
| Share Series | Dividend Type | Rate (%) | Dividend Paid ($/share) | ||
| Series 1 | Regular | 2.404 | $0.15025 | ||
| Series 2 | Regular | 2.259 | $0.14235 | ||
| Series 3 | Regular | 4.50 | $0.28125 | ||
| Series 5 | Regular | 4.50 | $0.28125 | ||
| Series 7 | Regular | 4.60 | $0.28750 | ||
Investor and Media Inquiries: Rob Knowles, Manager, Investor Relations 587-747-2116 Mel Duvall, Manager, Media & Issues 403-513-7602


BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 



